Advisory Committee

Lassen Peak Appoints Former London Metropolitan Police Deputy Assistant Commissioner, Graham McNulty QPM, to its Advisory Committee for the United Kingdom

Retrieved on: 
Wednesday, June 14, 2023

Mr. McNulty states, "I have witnessed first-hand the misery caused by knife crime and the impact that it has across all our communities. I'm excited and encouraged to be a part of Lassen Peak's mission of providing a safe, accurate detection device which will provide huge assistance to frontline cops trying to take knives off our streets. This technology will allow police officers to stop the right people, focusing on those individuals intent on causing harm within our communities. Policing is a challenging profession where officers on the ground are asked to make split second judgements -- it is important we provide them with the best equipment to keep us all safe."

Key Points: 
  • BELLEVUE, Wash., June 14, 2023 /PRNewswire/ -- Today, Lassen Peak announces the appointment of Graham McNulty to its Advisory Committee for the United Kingdom.
  • Throughout his 30-year career, Mr. McNulty has been an active leader in the U.K. policing community, including holding the National Police Chiefs' Council (NPCC) Lead for Knife-Enabled Crime and Gangs.
  • In January 2022, Mr. McNulty was awarded the Queen's Police Medal (QPM) by Her Majesty Queen Elizabeth II.
  • Mr. McNulty brings a wealth of relevant experience to the Lassen Peak Advisory Committee.

FDA ADVISORY COMMITTEE UNANIMOUSLY CONFIRMS EFFICACY AND CLINICAL BENEFIT OF LEQEMBI FOR EARLY ALZHEIMER'S DISEASE

Retrieved on: 
Friday, June 9, 2023

"The Alzheimer's Association welcomes and celebrates this action by the FDA Advisory Committee to support traditional approval of Leqembi for people with early Alzheimer's," said Joanne Pike, DrPH, Alzheimer's Association president and CEO.

Key Points: 
  • "The Alzheimer's Association welcomes and celebrates this action by the FDA Advisory Committee to support traditional approval of Leqembi for people with early Alzheimer's," said Joanne Pike, DrPH, Alzheimer's Association president and CEO.
  • The Alzheimer's Association and members of the Association's Early Stage Advisory Group each submitted comments urging the Advisory Committee to recommend traditional approval of Leqembi, which was granted accelerated approval in January 2023.
  • "We are in full agreement with the FDA Advisory Committee that Leqembi provides clinical benefit and that this benefit outweighs the risks.
  • Leqembi, an anti-amyloid treatment, changes the course of Alzheimer's and delivers clear clinical benefit for people in the early stages of the disease.

BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review NurOwn® Biologics License Application Scheduled for September 27, 2023

Retrieved on: 
Tuesday, June 6, 2023

NEW YORK, June 6, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) will convene a meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (ADCOM) to review the Biologics License Application (BLA) for NurOwn®, its investigational mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS). The advisory committee meeting has been scheduled for September 27, 2023, and will be available for live streaming. In addition, BrainStorm's BLA for NurOwn has a Prescription Drug User Fee Act (PDUFA) action date targeted to occur by December 8, 2023.

Key Points: 
  • The advisory committee meeting has been scheduled for September 27, 2023, and will be available for live streaming.
  • In addition, BrainStorm's BLA for NurOwn has a Prescription Drug User Fee Act (PDUFA) action date targeted to occur by December 8, 2023.
  • "We are encouraged by the regulatory flexibility that the FDA has shown over the last year in ALS broadly, and with respect to NurOwn in particular, and believe an Advisory Committee meeting is good for patients," said Chaim Lebovits, BrainStorm President & CEO.
  • Stacy Lindborg, Ph.D., BrainStorm co-CEO, commented: "We welcome the opportunity to present our data at the forthcoming ADCOM.

U.S. Small Business Administration Veterans Small Business Advisory Committees Set to Host Virtual Public Meetings June 7-8

Retrieved on: 
Friday, June 2, 2023

Today, the U.S. Small Business Administration (SBA) Interagency Task Force (IATF) on Veterans Small Business Development and Advisory Committee on Veterans Business Affairs (ACVBA) announced they will hold their next set of virtual public meetings on June 7 and 8, respectively, via Microsoft Teams.

Key Points: 
  • Today, the U.S. Small Business Administration (SBA) Interagency Task Force (IATF) on Veterans Small Business Development and Advisory Committee on Veterans Business Affairs (ACVBA) announced they will hold their next set of virtual public meetings on June 7 and 8, respectively, via Microsoft Teams.
  • "These meetings are a chance for the public, business owners, and other advocates to come together and discuss how the SBA can continue to serve and meet the needs of our Nation's veteran entrepreneurs," said Acting Associate Administrator for the SBA Office of Veterans Business Development Timothy Green.
  • "Each quarterly meeting represents an opportunity for committee members to contribute to the conversation on the state of veteran-owned small businesses."
  • The ACVBA meeting will cover briefings from the SBA Office of Veterans Business Development, the SBA Office of Government Contracting and Business Development on the Veteran Small Business Certification program, the VA, the SBA Office of Policy Planning, and the Madison Services Group.

Strong consumer protection and consumer education will be important for open banking in Canada

Retrieved on: 
Thursday, June 1, 2023

The public opinion research report published today will help inform the approach to open banking in Canada, in particular financial consumer protection policies and consumer education.

Key Points: 
  • The public opinion research report published today will help inform the approach to open banking in Canada, in particular financial consumer protection policies and consumer education.
  • The report's findings provide evidence that strong and consistent consumer protections and education will be essential to build trust, understanding and interest in open banking among Canadians.
  • Just 9% have heard of open banking, and not all who have heard of open banking fully understand it.
  • Information on the implementation of open banking in Canada is available from the Department of Finance: Open banking implementation .

Report From FINRA Board of Governors Meeting – May 2023

Retrieved on: 
Thursday, May 25, 2023

FINRA’s Board of Governors met on May 17-18 for the second time in 2023.

Key Points: 
  • FINRA’s Board of Governors met on May 17-18 for the second time in 2023.
  • During the meeting, the Board appointed a new public governor, approved FINRA’s 2022 Annual Financial Report and added new members to Advisory Committees.
  • Her research and scholarly interests include matters related to corporate and board governance, board fiduciary duties, board-shareholder engagement, board composition and diversity, board oversight, shareholder engagement and activism, affinity fraud, and securities fraud.
  • The next FINRA Board of Governors meeting is scheduled for July.

ICCSD: Leveraging the Power of AI for Sustainable Development across Multiple Sectors

Retrieved on: 
Friday, May 26, 2023

Attendees came together to explore the profound impact of artificial intelligence (AI) technology in advancing sustainable development in the modern era.

Key Points: 
  • Attendees came together to explore the profound impact of artificial intelligence (AI) technology in advancing sustainable development in the modern era.
  • Recognizing the potential of emerging technologies, many have called for their integration to expedite the SDGs.
  • Zhao Haiying, Professor at the School of Artificial Intelligence at Beijing University of Posts and Telecommunications, delivered a presentation on harnessing the power of AI to unlock the realms of cultural computing and cultural heritage.
  • By synergizing big data, AI, machine learning, and cultural history, the intricate nuances of cultural connotations could be explored, advancing the field of digital humanities research.

ICCSD: Harnessing the Power of AI for Enhanced Cultural Heritage Preservation

Retrieved on: 
Friday, May 26, 2023

At the event, experts from diverse fields came together to explore the applications of artificial intelligence (AI) across various domains.

Key Points: 
  • At the event, experts from diverse fields came together to explore the applications of artificial intelligence (AI) across various domains.
  • Shahbaz Khan, Director of the UNESCO Office Beijing, emphasized the potential of digitalization and AI to strengthen the preservation of cultural heritage, highlighting the significant progress made by ICCSD in this area.
  • Richard Leaver, an AI scientist and Fellow of the Royal Society, shed light on the latest advancements that ChatGPT can offer, discussing its technical implications and the benefits it brings to individuals and communities.
  • Their efforts have yielded new scientific and technological tools that benefit bird researchers, conservationists, and the general public, significantly enhancing the efficiency of biodiversity monitoring and conservation efforts.

ICCSD Convenes Advisory Committee Meeting to Explore AI's Role in Empowering Sustainable Development

Retrieved on: 
Friday, May 26, 2023

BEIJING, May 25, 2023 /PRNewswire/ -- A report from CRIOnline:

Key Points: 
  • BEIJING, May 25, 2023 /PRNewswire/ -- A report from CRIOnline:
    On May 23, the conference of the Advisory Committee of the International Center for Creativity and Sustainable Development (ICCSD) under the auspices of UNESCO was held in a hybrid format.
  • Members of the committee's board and guests gathered to delve into the future of ICCSD and the transformative power of artificial intelligence (AI) technology in advancing sustainable development in the new era.
  • The ICCSD aims to bridge the gap between tech culture and sustainable development, fostering exchanges among experts in diverse fields to collectively explore and unlock the full potential of AI.
  • The ICCSD Advisory Committee Chairman, Mr. d'Orville, said that AI is already being used to address many global and regional environmental problems in areas like biodiversity, water, energy, and transportation.

Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

Retrieved on: 
Friday, May 19, 2023

MORRISTOWN, N.J., May 19, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced the outcome of the U.S. Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) Meeting to review the Company’s New Drug Application (NDA) for obeticholic acid (OCA) for the treatment of pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH).

Key Points: 
  • “We continue to disagree with the FDA on certain characterizations of OCA’s efficacy and safety in pre-cirrhotic fibrosis due to NASH and the role of non-invasive tests (NITs), as discussed in today's meeting.
  • As previously reported, the FDA has assigned a Prescription Drug User Fee Act (PDUFA) Target Action Date of June 22, 2023.
  • The conference call will be available via a listen-only webcast on the investor page of the company’s website at http://ir.interceptpharma.com .
  • A replay of the call will be available on the Intercept website shortly following the completion of the call and will be available for one year.